VMI

VHCP Management III Portfolio holdings

AUM $504M
This Quarter Return
+34.01%
1 Year Return
+678.37%
3 Year Return
5 Year Return
10 Year Return
AUM
$214M
AUM Growth
+$214M
Cap. Flow
+$50.3M
Cap. Flow %
23.47%
Top 10 Hldgs %
93.72%
Holding
17
New
1
Increased
4
Reduced
8
Closed
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MIST icon
1
Milestone Pharmaceuticals
MIST
$156M
$56.1M 26.2%
+2,066,529
New +$56.1M
AXSM icon
2
Axsome Therapeutics
AXSM
$6.05B
$41.5M 19.37%
1,611,329
+543,285
+51% +$14M
RARX
3
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$20.2M 9.41%
670,350
+75,637
+13% +$2.27M
KALV icon
4
KalVista Pharmaceuticals
KALV
$678M
$14.1M 6.6%
637,884
-332,746
-34% -$7.37M
OBSV
5
DELISTED
ObsEva SA Ordinary Shares
OBSV
$13.1M 6.12%
1,159,789
PTGX icon
6
Protagonist Therapeutics
PTGX
$3.67B
$13M 6.06%
1,072,348
+263,025
+32% +$3.19M
LJPC
7
DELISTED
La Jolla Pharmaceutical Company
LJPC
$11.6M 5.41%
1,251,898
+248,298
+25% +$2.3M
TCDA
8
DELISTED
Tricida, Inc. Common Stock
TCDA
$11.4M 5.34%
289,746
-360,839
-55% -$14.2M
BCRX icon
9
BioCryst Pharmaceuticals
BCRX
$1.74B
$10.3M 4.79%
2,708,207
-352,884
-12% -$1.34M
ORTX
10
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$9.46M 4.42%
676,252
-134,778
-17% -$1.89M
MRNS
11
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$5.23M 2.44%
1,258,964
KNSA icon
12
Kiniksa Pharmaceuticals
KNSA
$2.48B
$4.23M 1.97%
312,320
-15,457
-5% -$209K
BLPH
13
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$1.45M 0.68%
2,417,227
KDMN
14
DELISTED
Kadmon Holdings, Inc.
KDMN
$870K 0.41%
422,141
-965,733
-70% -$1.99M
CNST
15
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$819K 0.38%
66,667
MTVA
16
MetaVia Inc. Common Stock
MTVA
$15.3M
$646K 0.3%
798,066
-71,472
-8% -$57.9K
KA
17
DELISTED
Kineta, Inc. Common Stock
KA
$216K 0.1%
221,267
-501,623
-69% -$490K